GlaxoSmithKline has agreed to extend its strategic relationship with South African-based Aspen Pharmacare Holdings Ltd., and will acquire a 16% share in the company. This is part of a broader agreement that includes combining commercial activities in Sub-Saharan Africa and the divestment of several assets to Aspen. Abbas Hussain, president emerging markets, GSK said, “Extending our strategic relationship with Aspen supports GSK’s strategy to accelerate sales growth in emerging mar...